AngioDynamics ANGO Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$8.08M-83.4% | -$6.35M+40.9% | -$10.9M+14.8% | -$6.05M+55.0% | -$4.41M+97.7% | ||
| $5.59M-11.5% | $5.75M-16.3% | $6.02M-11.3% | $5.83M-14.4% | $6.32M-16.0% | ||
| $2.68M+11.9% | $2.89M+14.4% | $4.47M+39.5% | $1.64M-13.4% | $2.4M-8.2% | ||
| —— | -$48K+80.7% | -$16K+95.3% | —— | -$207K+98.3% | ||
| $38K0.0% | $307K+687% | -$27K-235% | -$97K— | $38K— | ||
| $317K+123% | -$235K-299% | $108K-60.0% | $169K-47.0% | $142K-69.0% | ||
| $1.42M+199% | $1.57M— | -$139K+96.3% | -$447K+91.9% | $474K+128% | ||
| -$7.06M— | $3.28M+162% | $192K-95.3% | —— | —— | ||
| -$6.01M+45.2% | —— | -$10.7M+28.6% | —— | -$10.96M-162% | ||
| $4.08M-56.6% | —— | $5.53M+561% | -$12.55M-412% | $9.39M+263% | ||
| -$315K-950% | -$238K— | -$264K-118% | -$142K-164% | -$30K+90.0% | ||
| -$3.11M+76.4% | —— | -$15.91M+12.8% | —— | -$13.16M-5.1% | ||
| $1.02M-43.5% | $422K-47.1% | $731K-33.1% | $777K+37.3% | $1.8M+196% | ||
| -$1.51M+52.7% | -$1.62M+17.3% | -$1.55M+35.5% | -$2.62M— | -$3.19M-111% | ||
| $0— | $0-100% | $0-100% | —— | —— | ||
| $716K-20.0% | —— | $234K+444% | —— | $895K+29.0% | ||
| $95K+63.8% | $92K— | $91K— | $90K— | $58K— | ||
| $621K-91.3% | —— | $143K+128% | -$5.77M-15.4% | $7.15M— | ||
| $168K+231% | —— | $191K+64.7% | $715K— | -$128K— | ||
| -$3.83M+59.0% | —— | -$17.13M+18.6% | —— | -$9.33M-153% | ||
| —— | —— | —— | $46.25K— | $46.25K— | ||
| —— | —— | —— | $200K+75.8% | $200K+75.8% | ||
| —— | —— | —— | $68K-37.0% | $68K-37.0% | ||
| $0-100% | $0-100% | $0-100% | —— | $40K-64.3% | ||
| —— | —— | —— | -$247K+87.6% | -$247K+87.6% | ||
| —— | —— | —— | $0-100% | $0-100% | ||
| $38K0.0% | $307K+687% | -$27K-235% | —— | $38K-99.4% | ||
| $4.08M-56.6% | —— | $5.53M+561% | -$12.55M-412% | $9.39M+263% | ||
| $72K— | —— | —— | —— | $0— | ||
| $350K-30.4% | $405K-18.8% | $445K-9.9% | —— | $503K+3.9% | ||
| —— | —— | —— | $489.5K+1.4% | $489.5K+1.4% | ||
| -$315K-950% | -$238K— | -$264K-118% | -$142K-164% | -$30K+90.0% | ||
| $317K+123% | -$235K-299% | $108K-60.0% | $169K-47.0% | $142K-69.0% | ||
| —— | —— | —— | $0+100% | $0+100% | ||
| —— | —— | —— | $1.43M+13.9% | $1.43M+13.9% | ||
| —— | —— | —— | $0-100% | $0-100% | ||
| $95K+63.8% | $92K— | $91K— | $90K— | $58K— | ||
| $716K-20.0% | —— | $234K+444% | —— | $895K+29.0% | ||
| —— | —— | —— | $233.25K+24.1% | $233.25K+24.1% | ||
| —— | —— | —— | $46.25K— | $46.25K— | ||
| -$445K-10.1% | $524K+18.3% | -$94K-194% | -$56K+75.2% | -$404K-241% | ||
| $492K-64.6% | $1.2M+3.0% | $820K-37.5% | —— | $1.39M+12.3% | ||
| —— | —— | —— | $0— | $0— | ||
| —— | —— | —— | $1.58M— | $1.58M— | ||
| —— | —— | —— | $200K+75.8% | $200K+75.8% | ||
| -$4.13M+72.4% | —— | -$16.65M+14.0% | —— | -$14.96M-13.9% | ||
| -$4.13M+72.4% | —— | -$16.65M+14.0% | —— | -$14.96M-13.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AngioDynamics generate?
- AngioDynamics (ANGO) generated -$50.4M in operating cash flow over the trailing twelve months.
- What is AngioDynamics's free cash flow?
- After $2.9M of capital expenditures, AngioDynamics's free cash flow was -$55.1M over the trailing twelve months, up 26.8% year over year.
- Where does AngioDynamics's cash flow data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
